The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen

The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen

ObjectiveBortezomib is one of the important drugs that have made breakthrough progress in multiple myeloma (MM) in the past 10 years. However, the heterogeneity of its efficacy makes it difficult to predict the risk of disease progression. The purpose of this study is to determine the prognostic sig...

Full description

Bibliographic Details
Main Authors: Yanbin Pang, Hong Shao, Ziheng Yang, Lixia Fan, Wenwen Liu, Jianhong Shi, Yuqing Wang, Ying Han, Lin Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
(neutrophils + monocytes)/lymphocytes ratio
prognostic factor
progression-free survival
bortezomib
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01617/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01617/full

Similar Items